David Quan, PharmD

Title(s)Pharmacist, COO
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPHA Primary Practice Residency1992 Pharmacy
    University of California, San Francisco Residency 1991School of Pharmacy

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Radhakrishnan K, Chi A, Quan DJ, Roberts JP, Terrault NA. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients. Transplantation. 2017 09; 101(9):2079-2082. PMID: 28880197.
      View in: PubMed
    2. Burrell C, Tsourounis C, Quan D, Jue V, Tam E, Guglielmo BJ. Impact of a pharmacist-driven protocol to improve drug allergy documentation at a university hospital. Hosp Pharm. 2013 Apr; 48(4):302-7. PMID: 24421479; PMCID: PMC3839456.
    3. Hickey MD, Quan DJ, Chin-Hong PV, Roberts JP. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation. Liver Transpl. 2013 Apr; 19(4):457-61. PMID: 23526600.
      View in: PubMed
    4. Dong K, Quan DJ. Appropriately assessing renal function for drug dosing. Nephrol Nurs J. 2010 May-Jun; 37(3):304-8. PMID: 20629469.
      View in: PubMed
    5. Quan DJ. Pharmacotherapy of hepatitis C virus infection: a brief review. Nephrol Nurs J. 2009 May-Jun; 36(3):333-7. PMID: 19588704.
      View in: PubMed
    6. Quan DJ. A brief history in nephrology pharmacotherapy. Nephrol Nurs J. 2009 Mar-Apr; 36(2):223-7. PMID: 19397179.
      View in: PubMed
    7. Quan DJ. Pharmacotherapy of hepatitis B infection: a brief review. Nephrol Nurs J. 2008 Sep-Oct; 35(5):507-10, 534. PMID: 18856082.
      View in: PubMed
    8. Quan DJ. A primer on pharmacokinetics. Nephrol Nurs J. 2008 Mar-Apr; 35(2):213-5. PMID: 18472692.
      View in: PubMed
    9. Niemann CU, Behrends M, Quan D, Eilers H, Gropper MA, Roberts JP, Hirose R. Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores. Transfus Med. 2006 Apr; 16(2):93-100. PMID: 16623915.
      View in: PubMed
    10. Quan DJ, Peters MG. Antiviral therapy: nucleotide and nucleoside analogs. Clin Liver Dis. 2004 May; 8(2):371-85. PMID: 15481345.
      View in: PubMed
    11. Reinus JF, Persky S, Burkiewicz JS, Quan D, Bass NM, Davern TJ. Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast. Ann Intern Med. 2000 Dec 19; 133(12):964-8. PMID: 11119397.
      View in: PubMed
    12. Chang GJ, Mahanty HD, Quan D, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated. Liver Transpl. 2000 Nov; 6(6):734-40. PMID: 11084060.
      View in: PubMed
    13. Hirose R, Roberts JP, Quan D, Osorio RW, Freise C, Ascher NL, Stock PG. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. Transplantation. 2000 Jan 27; 69(2):307-11. PMID: 10670644.
      View in: PubMed